Early ambulation and discharge in 100 patients with burns of the foot treated by grafts.
Traditional treatment after grafting of foot, ankle, and lower leg burns is bedrest, limb elevation, and gradual ambulation only after 5 to 10 days. In 1982 we suggested that aggressive surgical treatment and early ambulation could shorten hospital stay and decrease morbidity. Our treatment of these burns is excision and grafting, application of an Unna (dome paste) boot immediately in the operating room or the next morning, with normal ambulation 4 hours later and discharge of the patient if there are no other reasons for continued hospitalization. This paper reports the continuation of this plan in 100 patients treated since 1982 with a mean age of 28.8 +/- 16.9 (SD) years and burn size of 3.7% +/- 4.4%. Sheet grafts were applied to 64% with a 96% take and narrowly meshed grafts to 36% with a 97% take. Results were excellent in 85 patients, satisfactory in ten, and poor in three who required another graft. Return to work was in 4.7 +/- 3 weeks. Unna boot application permits immediate ambulation, avoids frequent dressing changes, permits a brief or no hospital stay, and provides excellent graft take with prompt return to work.
Grube
B J
BJ
Department of Surgery, University of Washington, Seattle.
Engrav
L H
LH
Heimbach
D M
DM
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D002056:Burns / Q000503:physiopathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols / Q000592:standards; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004434:Early Ambulation / Q000592:standards*; D005500:Follow-Up Studies; D018409:Foot Injuries; D005780:Gelatin / Q000008:administration & dosage / Q000627:therapeutic use*; D005990:Glycerol / Q000008:administration & dosage / Q000627:therapeutic use*; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D007902:Length of Stay / Q000706:statistics & numerical data; D008875:Middle Aged; D010351:Patient Discharge / Q000592:standards*; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012086:Reoperation / Q000706:statistics & numerical data; D016038:Skin Transplantation / Q000592:standards*; D016896:Treatment Outcome; D014861:Washington / Q000453:epidemiology; D015034:Zinc Oxide / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D005780:Gelatin; D005990:Glycerol; D015034:Zinc Oxide